PT-141 — MC3R/MC4R Melanocortin Receptor Agonist | Research Grade Peptide
$ 75.00 - or subscribe
PT-141 is a 7-amino-acid synthetic melanocortin receptor agonist peptide studied for its central nervous system effects on MC3R and MC4R receptor pathway signaling in research models. Supplied as a lyophilized vial for in-vitro laboratory research use only.
Research-grade specs
- Sequence length: 7 amino acids
- Class: Melanocortin receptor agonist (MC4-R focus)
- Half-life: ~2 hours
Studied applications
- MC4-R receptor research
- CNS-mediated melanocortin receptor pathway studies
- Comparative melanocortin agonist research
Quality & trust
- ≥99% HPLC purity, third-party tested
- Mass spectrometry identity confirmation
- LAL endotoxin testing on every batch
- Batch-specific Certificate of Analysis included
- USA same-day shipping (orders before 2pm CT M-F)
Research literature
Bremelanotide has been the subject of 103 peer-reviewed publications indexed in PubMed. Selected recent literature for research reference:
- Pfaus JG et al. (2026). Should Bremelanotide Be Considered for the Treatment of Sexual Arousal and Desire Disorders in Men?. J Clin Psychopharmacol. PMID: 41960633
- Toledo RG et al. (2026). Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options. J Minim Invasive Gynecol. PMID: 40543759
- Mihulka O et al. (2025). Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer. J Minim Invasive Gynecol. PMID: 41419078
- Fuhrman J et al. (2025). Practical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies. Expert Rev Clin Pharmacol. PMID: 41088800
- Bardhan M et al. (2025). Polymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and Diseases. Diseases. PMID: 41002740
References are provided for research reference only. Inclusion of literature does not constitute a recommendation, endorsement, or claim for any specific use of LiveWell Peptides products. Products are sold for laboratory and research use only and are not intended for human consumption, injection, topical application, or any other administration to the human body.
| Quantity | Price | Discount |
|---|---|---|
| 3-5 | $ 72.00 | 4% |
| 6-8 | $ 69.00 | 8% |
| 10-15 | $ 66.75 | 11% |
| 16+ | $ 75.00 | $ 0.00 |
Description
PT-141 is a synthetic 7-amino-acid melanocortin receptor agonist peptide investigated for its effects on MC3R and MC4R receptor pathway interactions in controlled laboratory settings. This lyophilized research compound is supplied strictly for in-vitro research use only and is not intended for human or veterinary use. Available in 10mg vial format with ≥99% HPLC purity and a batch-specific Certificate of Analysis included.
⚠️ Research Use Only. Not for human consumption, veterinary use, or clinical application. Not evaluated by the FDA. Must be 21+ to purchase.
Reference Link: Click Here
You may also like
5-Amino-1MQ — NNMT Inhibitor | Research Grade
$ 45.99 - or subscribe and save up to 10%
BPC-157 Peptide — Body Protection Compound | Research Grade
$ 85.99 - or subscribe
CJC-1295 ( no DAC) + IPAMORELIN
Price range: $ 85.00 through $ 115.00 - or subscribe
